Trial Profile
Pharmacokinetics and metabolism of [14C] BMS-275183 in patients with advanced cancer
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 09 Mar 2010
Price :
$35
*
At a glance
- Drugs BMS 275183 (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 04 Jul 2007 New trial record.